Ublituximab
HP-00113916
Unknown small_molecule active
Quick answer
Ublituximab for Multiple Sclerosis (MS) - Relapsing-remitting is a Unknown program (small_molecule) at TG THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TG THERAPEUTICS, INC.
- Indication
- Multiple Sclerosis (MS) - Relapsing-remitting
- Phase
- Unknown
- Modality
- small_molecule
- Status
- active